DK63287A - Vacciner imod melanoma - Google Patents

Vacciner imod melanoma

Info

Publication number
DK63287A
DK63287A DK063287A DK63287A DK63287A DK 63287 A DK63287 A DK 63287A DK 063287 A DK063287 A DK 063287A DK 63287 A DK63287 A DK 63287A DK 63287 A DK63287 A DK 63287A
Authority
DK
Denmark
Prior art keywords
vaccines against
against melanoma
melanoma
vaccines
Prior art date
Application number
DK063287A
Other languages
Danish (da)
English (en)
Other versions
DK63287D0 (da
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK63287(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of DK63287D0 publication Critical patent/DK63287D0/da
Publication of DK63287A publication Critical patent/DK63287A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK063287A 1986-02-07 1987-02-06 Vacciner imod melanoma DK63287A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (2)

Publication Number Publication Date
DK63287D0 DK63287D0 (da) 1987-02-06
DK63287A true DK63287A (da) 1987-08-08

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
DK063287A DK63287A (da) 1986-02-07 1987-02-06 Vacciner imod melanoma

Country Status (18)

Country Link
JP (3) JP2664673B2 (sv)
BE (1) BE1000175A3 (sv)
CH (1) CH675424A5 (sv)
DE (1) DE3703702C2 (sv)
DK (1) DK63287A (sv)
ES (2) ES2012815A6 (sv)
FI (1) FI94836C (sv)
GR (1) GR870195B (sv)
HU (1) HU209144B (sv)
IE (1) IE59597B1 (sv)
IT (1) IT1222359B (sv)
MX (1) MX9203574A (sv)
NL (1) NL8700285A (sv)
NO (1) NO178931C (sv)
NZ (1) NZ219192A (sv)
OA (1) OA08478A (sv)
PT (1) PT84255B (sv)
SE (2) SE506024C2 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
NZ219192A (en) 1991-10-25
IE59597B1 (en) 1994-03-09
FI94836C (sv) 1995-11-10
HU209144B (en) 1994-03-28
FI870501A0 (sv) 1987-02-06
DK63287D0 (da) 1987-02-06
IT1222359B (it) 1990-09-05
FI870501A (sv) 1987-08-08
PT84255A (en) 1987-03-01
ES2012815A6 (es) 1990-04-16
OA08478A (fr) 1988-07-29
SE9202934D0 (sv) 1992-10-07
HUT43107A (en) 1987-09-28
NO870475D0 (no) 1987-02-06
SE8700466L (sv) 1987-08-08
NL8700285A (nl) 1987-09-01
JPH09135692A (ja) 1997-05-27
IT8719291A0 (it) 1987-02-06
SE8700466D0 (sv) 1987-02-06
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
JPS62294698A (ja) 1987-12-22
JPH08280390A (ja) 1996-10-29
NO870475L (no) 1987-08-10
JP2664673B2 (ja) 1997-10-15
ES2017258A6 (es) 1991-01-16
FI94836B (sv) 1995-07-31
GR870195B (en) 1987-06-10
BE1000175A3 (fr) 1988-07-12
IE870319L (en) 1987-08-07
DE3703702C2 (de) 1997-07-10
CH675424A5 (en) 1990-09-28
NO178931C (no) 1996-07-03
DE3703702A1 (de) 1988-02-18
MX9203574A (es) 1992-07-01
NO178931B (no) 1996-03-25

Similar Documents

Publication Publication Date Title
IL81481A0 (en) Vaccines against melanoma
DE3752263D1 (de) Impfstoffe
KR880007034U (ko) 재크
DK111187D0 (da) Tandbehandlingsmiddel
DE3776945D1 (de) Optischer kopf.
NO168397C (no) Laseranordning
GB2188637B (en) Vaccines against melanoma
KR880013257U (ko) 광헤드
DE3778670D1 (de) Optischer kopf.
TR24926A (tr) Diflufenikan kullanan herbisidal usul
DK63287A (da) Vacciner imod melanoma
DK589287D0 (da) Laser
DE3788743D1 (de) Optischer Kopf.
DE3760706D1 (de) Fluidizer
DK574187A (da) Analgetiske praeparater
DK406888A (da) Stige
IT8748281A0 (it) Testata per proietto
DE3774630D1 (de) Optischer kopf.
DK159524C (da) Beskyttelseshjelm
ES1005502Y (es) Cabeza extendedora
KR880000198U (ko) 화장품 케이스
KR880000197U (ko) 화장품 케이스
CA57576S (fr) Vitrine
KR880001837U (ko) 쇼우 케이스
ES1000722Y (es) Caballete mejorado

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment